Covered recipient · General Payments record
AMIT G PANDYA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$314,527.80
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $28,825.00 | 6 |
| Food and Beverage | $108.14 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $16,800.00 | 2 |
| Eli Lilly and Company | $6,400.00 | 2 |
| Incyte Corporation | $5,625.00 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.03 | 2 |
| E.R. Squibb & Sons, L.L.C. | $22.63 | 1 |
| Arcutis Biotherapeutics, Inc. | $22.08 | 1 |
| PFIZER INC. | $13.40 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15,200.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105175192 | CMS |
| ABBVIE INC. | $1,600.00 | 06/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105175194 | CMS |
| Arcutis Biotherapeutics, Inc. | $22.08 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121034174 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.63 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101783600 | CMS |
| Eli Lilly and Company | $4,000.00 | 03/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135997753 | CMS |
| Eli Lilly and Company | $2,400.00 | 04/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136030918 | CMS |
| Incyte Corporation | $4,125.00 | 03/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141298105 | CMS |
| Incyte Corporation | $1,500.00 | 03/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141270878 | CMS |
| Novartis Pharmaceuticals Corporation | $26.87 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087342781 | CMS |
| Novartis Pharmaceuticals Corporation | $23.16 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087342783 | CMS |
| PFIZER INC. | $7.17 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131294252 | CMS |
| PFIZER INC. | $6.23 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131491064 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.